Altamira Therapeutics Ltd
NASDAQ:CYTO

Watchlist Manager
Altamira Therapeutics Ltd Logo
Altamira Therapeutics Ltd
NASDAQ:CYTO
Watchlist
Price: 1.53 USD 4.08% Market Closed
Updated: Jun 2, 2024

Altamira Therapeutics Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Altamira Therapeutics Ltd
Selling, General & Administrative Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Altamira Therapeutics Ltd
NASDAQ:CYTO
Selling, General & Administrative
-CHf3m
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Novartis AG
SIX:NOVN
Selling, General & Administrative
-$15.3B
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Roche Holding AG
SIX:ROG
Selling, General & Administrative
-CHf13.5B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
S
Sandoz Group AG
SIX:SDZ
Selling, General & Administrative
-$2.4B
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Altamira Therapeutics Ltd's Selling, General & Administrative?
Selling, General & Administrative
-3m CHF

Based on the financial report for Dec 31, 2023, Altamira Therapeutics Ltd's Selling, General & Administrative amounts to -3m CHF.

What is Altamira Therapeutics Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
6%

Over the last year, the Selling, General & Administrative growth was 50%. The average annual Selling, General & Administrative growth rates for Altamira Therapeutics Ltd have been -5% over the past three years , 6% over the past five years .